Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...
Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...
Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...
US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...
These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s ...
Following the recent news that Dr Reddy's Laboratories (DRL) has agreed to acquire Wockhardt Ltd’s select division...
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...
Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...
Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...
Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...
Dr. Reddy’s Laboratories along with its subsidiaries, together referred to as “Dr. Reddy’s confirms it...
Japan headquartered Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have announced that they have entered into a comprehens...
Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...
Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...
Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an a...
Teva Pharmaceutical Industries has announced the availability of the FDA-approved generic version of EpiPen Jr®1&nbs...
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...
